A pioneer review on lactoferrin as versatile macromolecular ligand for targeting cancer: recent advances
- 14 July 2025
- journal article
- review article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 33 (10) , 1788-1806
Abstract
This study critically examines recent developments in the use of lactoferrin, a multi-functional iron-chelating glycoprotein, as a macromolecular ligand for precision cancer therapy. The study highlights the molecular mechanism of lactoferrin, nano-formulation based novel approaches, and its synergistic potential to surmount therapeutic limitations inherent to precision oncology. Lactoferrin, found in milk and mucosal secretions, exhibits intense anti-tumor, anti-inflammatory, and immunomodulatory activities. Lactoferrin binds with high affinity to cancer cell-specific receptors, such as transferrin and low-density lipoprotein receptor-related proteins, allowing for selective targeting and internalization and limiting off-target toxicity. Lactoferrin modulates oncogenic pathways like PI3K/Akt and MAPK, and potently inhibits tumor growth and metastasis. Pharmacokinetic profiles are enhanced and drug release is made tumor-directed by nanoformulations such as liposomes and polymeric nanoparticles, respectively, enhancing the efficacy of conventional chemotherapeutics. Lactoferrin penetration of biological barriers like the blood-brain barrier by receptor-mediated transcytosis offers new platforms for therapy of intractable cancers such as glioblastoma. Moreover, its immunomodulatory effects, such as the activation of NK cells and macrophage polarization to an M1 phenotype, enhance anti-tumor immunity, respectively, complementing immunotherapeutic approaches. The study also elaborates on the roles of lactoferrin in overcoming multidrug resistance through the modulation of efflux pumps like P-glycoprotein. The review thoroughly integrates molecular, preclinical, and clinical characteristics, highlighting lactoferrin's revolutionary potential in precision oncology by advanced nano formulations and synergistic immunomodulatory activity.Keywords
This publication has 142 references indexed in Scilit:
- Comparative Analysis of Two Elastic Types of Surface‐Crosslinked Gelatin Nanoparticles as Suitable Systems for Macromolecular Drug DeliveryMacromolecular Chemistry and Physics, 2025
- Structural and in vitro anticancer properties of the kaempferol–lactoferrin complexFood Science & Nutrition, 2024
- Evasion of opsonization of macromolecules using novel surface‐modification and biological‐camouflage‐mediated techniques for next‐generation drug deliveryCell Biochemistry and Function, 2023
- Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and DeliveryAdvanced Science, 2023
- Targeted Therapy and Personalized Medicine2023
- Cellular Iron Metabolism and Regulation2019
- Holo‐Lactoferrin Modified Liposome for Relieving Tumor Hypoxia and Enhancing Radiochemotherapy of CancerSmall, 2019
- LactoferrinCellular and Molecular Life Sciences, 2005
- Bovine lactoferrin inhibits tumor‐induced angiogenesisInternational Journal of Cancer, 2004
- Three-Dimensional Structure of Lactoferrin in Various Functional States1994